Skip to content

Clinical trials

Phase 2 Biliary Tract Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20103
20111
20141
20154
20161
20174
20183
20196
20204
20213
20223
20234
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status9
Recruiting5
Active, not recruiting4
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center5
Samsung Medical Center4
AstraZeneca3
Bayer2
Changhoon Yoo2
Hallym University Medical Center2
Jazz Pharmaceuticals2
Seoul National University Hospital2
Yonsei University2
Basilea Pharmaceutica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms41
Cholangiocarcinoma8
Colorectal Neoplasms7
Stomach Neoplasms7
Pancreatic Neoplasms6
Gallbladder Neoplasms5
Breast Neoplasms4
Gastrointestinal Stromal Tumors4
Neoplasms4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.